Berman Capital Advisors, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Berman Capital Advisors, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$11,000
-38.9%
261
-21.4%
0.00%
-33.3%
Q2 2021$18,000
-25.0%
3320.0%0.00%
-40.0%
Q1 2021$24,000
-14.3%
3320.0%0.01%
-28.6%
Q4 2020$28,000
+40.0%
3320.0%0.01%
+16.7%
Q3 2020$20,000
+100.0%
332
+28.7%
0.01%
+100.0%
Q2 2020$10,000
+900.0%
258
+616.7%
0.00%
Q1 2020$1,000
-66.7%
36
+28.6%
0.00%
-100.0%
Q3 2019$3,000
-40.0%
280.0%0.00%
-50.0%
Q2 2019$5,000
+25.0%
280.0%0.00%
+100.0%
Q1 2019$4,000280.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders